Gout Trials in Covina, United States
Conditions / Gout / Covina, United States
Gout is a medical condition with active clinical research programs worldwide.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05586958 | Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients | COMPLETED | PHASE3 |
| NCT01508702 | Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors | COMPLETED | PHASE3 |
| NCT06229145 | A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout | ACTIVE_NOT_RECRUITING | PHASE4 |
| NCT04511702 | Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate | COMPLETED | PHASE4 |
| NCT01510158 | Combining Lesinurad With Allopurinol in Inadequate Responders | COMPLETED | PHASE3 |
| NCT01391325 | Allopurinol Outcome Study | COMPLETED | PHASE4 |
| NCT03226899 | A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment | TERMINATED | PHASE4 |
| NCT02139046 | Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout | COMPLETED | PHASE3 |
| NCT07089875 | A Study of Dotinurad Versus Allopurinol in Participants With Gout | RECRUITING | — |
| NCT01650246 | Open-Label Lesinurad Monotherapy Extension Study in Gout | COMPLETED | PHASE3 |